Quarterly Report for Quarter Ending September 30, 2024 (Form 10-Q)
Madrigal Pharmaceuticals, Inc. Announces Participation at Three[...]
Taysha Gene Therapies to Release Third Quarter 2024 Financial Results[...]
11/06/2024 | Press release | Distributed by Public on 11/06/2024 07:05
Please select the service you want to use:
Smartlinks | Ocular Therapeutix Inc. | News | Health | Company News | Top Company News | Corporate and Financial Calendar | Pharmaceuticals | Securities Issuers | Pharmaceutical Companies | Frankfurt Stock Exchange | Berlin Stock Exchange | Dusseldorf Stock Exchange | Stuttgart Stock Exchange | BX Swiss | Tradegate Exchange | NYSE American | NYSE ARCA Equities | Nasdaq Global Market | Cboe BZX Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | NYSE National | FINRA Alternative Display Facility (ADF) | Nasdaq BX | Nasdaq PSX | NYSE Chicago
Back
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact